The voice of postsurgical lung cancer patients regarding supportive care needs

JOURNAL ARTICLE published April 2014 in Lung Cancer: Targets and Therapy

Authors: Amy Hoffman | Ruth Ann Brintnall | Alexander von Eye | Julie Cooper | Jean K. Brown

<p>Orphan Drugs in Development for the Treatment of Small-Cell Lung Cancer: Emerging Data on Lurbinectedin</p>

JOURNAL ARTICLE published March 2020 in Lung Cancer: Targets and Therapy

Authors: Diego Kauffmann-Guerrero | Rudolf M Huber

<p>Landscape on CT screening for lung cancer in Asia</p>

JOURNAL ARTICLE published September 2019 in Lung Cancer: Targets and Therapy

Authors: Natthaya Triphuridet | Claudia Henschke

New PD-L1 inhibitors in non-small cell lung cancer &ndash; impact of atezolizumab

JOURNAL ARTICLE published July 2017 in Lung Cancer: Targets and Therapy

Authors: Nagashree Seetharamu | Isabel Preeshagul | Kevin Sullivan

The Nail in the Coffin?: Examining the KEYNOTE-789 Clinical Trial’s Impact

JOURNAL ARTICLE published January 2024 in Lung Cancer: Targets and Therapy

Authors: Zhaohui Arter | Misako Nagasaka

<p>Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study</p>

JOURNAL ARTICLE published December 2020 in Lung Cancer: Targets and Therapy

Authors: David Lang | Wolfgang Haslinger | Kaveh Akbari | Mario Scala | Benedikt Hergan | Christian Asel | Andreas Horner | Romana Wass | Elmar Brehm | Bernhard Kaiser | Bernd Lamprecht

Economic evaluation of pemetrexed versus erlotinib as second-line treatment of patients with advanced/metastatic non-small cell lung cancer in Greece: a cost minimization analysis

JOURNAL ARTICLE published July 2012 in Lung Cancer: Targets and Therapy

Authors: Vassilis Fragoulakis | Athanasios Pallis

Epiregulin as a therapeutic target in non-small-cell lung cancer

JOURNAL ARTICLE published October 2015 in Lung Cancer: Targets and Therapy

Authors: Noriaki Sunaga | Kyoichi Kaira

Exhaled breath analysis for the early detection of lung cancer: recent developments and future prospects

JOURNAL ARTICLE published May 2017 in Lung Cancer: Targets and Therapy

Authors: Inbar Nardi-Agmon | Nir Peled

Comparative effectiveness and safety of <em>nab</em>-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting

JOURNAL ARTICLE published October 2017 in Lung Cancer: Targets and Therapy

Authors: Raja Mudad | Manish B Patel | Sandra Margunato-Debay | David Garofalo | Lincy S Lal

Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges

JOURNAL ARTICLE published May 2021 in Lung Cancer: Targets and Therapy

Authors: Toshio Fujino | Kenichi Suda | Tetsuya Mitsudomi

Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response

JOURNAL ARTICLE published November 2017 in Lung Cancer: Targets and Therapy

Authors: Ewa Wojcik | Jan Kulpa

New options in the management of intractable ALK(+) metastatic non-small-cell lung cancer

JOURNAL ARTICLE published August 2014 in Lung Cancer: Targets and Therapy

Authors: Shirish Gadgeel | Amy Weise

Gastroesophageal junction adenocarcinoma displays abnormalities in homologous recombination and nucleotide excision repair

JOURNAL ARTICLE published February 2014 in Lung Cancer: Targets and Therapy

Authors: Shadia Jalal | Robin I Dewalt | Kenneth A Kesler | Zane T Hammoud | LeeAnn Baldridge | Eyas M Hattab

Clinical outcomes following advanced respiratory motion management (respiratory gating or dynamic tumor tracking) with stereotactic body radiation therapy for stage I non-small-cell lung cancer

JOURNAL ARTICLE published November 2018 in Lung Cancer: Targets and Therapy

Authors: Paul Aridgides | Tamara Nsouli | Rishabh Chaudhari | Russell Kincaid | Paula F Rosenbaum | Sean Tanny | Michael Mix | Jeffrey Bogart

An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece

JOURNAL ARTICLE published August 2021 in Lung Cancer: Targets and Therapy

Authors: Giannis Mountzios | Sofia Lampaki | Georgia-Angeliki Koliou | Athanassios Vozikis | Ioannis Kontogiorgos | Panagiotis Papantoniou | Margarita-Ioanna Koufaki | Eleni Res | Anastasios Boutis | Athina Christopoulou | Nicoleta Pastelli | Anastasios Grivas | Gerasimos Aravantinos | Efthalia Lalla | Georgios Oikonomopoulos | Anna Koumarianou | Dionisiοs Spyratos | Dimitrios Bafaloukos | Georgios Rigakos | Pavlos Papakotoulas | George Fountzilas | Helena Linardou

Profile of ceritinib in the treatment of ALK+ metastatic non-small-cell lung cancer

JOURNAL ARTICLE published May 2015 in Lung Cancer: Targets and Therapy

Authors: Eric Kim | Mark Burns

Gefitinib frequently induces liver damage in patients with lung adenocarcinoma previously treated by chemotherapy

JOURNAL ARTICLE published June 2013 in Lung Cancer: Targets and Therapy

Authors: Yasoo Sugiura | Etsuo Nemoto | Yasuyuki Ohkubo | Hisae Fusegawa | Shizuka Kaseda

Driver oncogenes in Sub-Saharan African patients with non-small cell lung cancer

JOURNAL ARTICLE published November 2016 in Lung Cancer: Targets and Therapy

Authors: Barbara Legius | Sandra Van Den Broecke | Inge Muylle | Vincent Ninane

Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan

JOURNAL ARTICLE published October 2017 in Lung Cancer: Targets and Therapy

Authors: Hiroshi Isobe | Kiyoshi Mori | Koichi Minato | Hideki Katsura | Kazuko Taniguchi | Ashwini Arunachalam | Smita Kothari | Xiting Cao | Terufumi Kato